(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 16.58% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 11.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,594.3%.
Iradimed's revenue in 2026 is $80,511,268.On average, 4 Wall Street analysts forecast IRMD's revenue for 2026 to be $1,194,007,702, with the lowest IRMD revenue forecast at $1,136,966,039, and the highest IRMD revenue forecast at $1,240,071,008.
In 2027, IRMD is forecast to generate $1,312,314,453 in revenue, with the lowest revenue forecast at $1,246,673,288 and the highest revenue forecast at $1,366,124,943.